A recently published review outlines the approach to the treatment of venous thromboembolism in pregnancy using patient case studies from their clinical practice in a Netherlands-based academic hospital.
Kidney injury may be less among patients with chronic kidney disease and atrial fibrillation taking apixaban versus warfarin for anticoagulation, new research suggests.
Low-intensity warfarin therapy was found to be as effective as standard-intensity I warfarin in lowering the risk for thromboembolism in older patients with nonvalvular atrial fibrillation.
Expert consensus decision pathway for anticoagulant and antiplatelet use in patients with atherosclerotic cardiovascular disease or in those with atrial fibrillation or venous thromboembolism undergoing percutaneous coronary intervention.
In patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation, early extracorporeal membrane oxygenation-facilitated resuscitation was found to improve survival to hospital discharge.
Edoxaban was found to be superior to placebo for the prevention of stroke and systemic embolism in very elderly Japanese patients with nonvalvular atrial fibrillation.
Investigators examined the effects of rivaroxaban (20 mg once daily) vs dose-adjusted warfarin in patients with atrial fibrillation and a bioprosthetic mitral valve.
Cryoballoon ablation is superior to drug therapy as an initial treatment for the prevention of atrial arrhythmia recurrence in patients with paroxysmal atrial fibrillation.
The authors of a letter to the editor recommend caution when altering oral anticoagulants prescriptions for patients with postoperative atrial fibrillation.
